Award
National Institute of Allergy and Infectious Diseases 1R56AI203781-01
Improving the Innate Activity of Broadly Neutralizing Vectored Antibodies Against HIV
Recipient
Massachusetts General Hospital
Award Amount
$1,032,783.00
Ceiling
$1,032,783.00
Awarded
July 28, 2026
Identifier
1R56AI203781-01
Award for research to improve innate activity of broadly neutralizing vectored antibodies against HIV, funded by NIH/NIAID, focusing on immunoengineering and gene transfer technologies.
Description
The project involves research on HIV prevention using AAV vectors and broadly neutralizing antibodies. The project aims to enhance innate immune functions to prevent HIV transmission. It is funded by NIH/NIAID and is part of a multi-year grant focusing on immunoengineering and gene transfer technologies.